EUVIMED · CrossrefJournal
Clinical Infectious Diseases
ISSN 1058-4838 · Oxford University Press (OUP)
Latest articles
2026 IDSA Clinical Practice Guidelines on Prevention of Invasive Aspergillosis in Adult Solid Organ Transplant Recipients
2026 IDSA Clinical Practice Guidelines on Prevention of Invasive Aspergillosis in Adult Solid Organ Transplant Recipients
2026 IDSA Clinical Practice Guidelines on Prevention of Invasive Aspergillosis in Adult Solid Organ Transplant Recipients – Lung and Heart Transplant Recipients
Dioscorides
Pharmacokinetic/Pharmacodynamic Analysis of Standard- and High-Dose Rifampicin to Predict Safety, Completion, and Tolerability of Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial
Prevalence of Powassan Virus Infection in Children with Suspected Lyme Disease
Looking beyond the tip of the iceberg: Powassan virus infections among children with Lyme disease
Antibiotic timing for sepsis without shock: an unexplained shift in IDSA's position
Clarifying IDSA's Position on Antibiotic Timing in Sepsis: Distinguishing Hospital Strategies from Clinical Guidance
Trial Endpoints for Endemic Mycoses: Consensus Recommendations by the Mycoses Study Group Education and Research Consortium and European Confederation of Medical Mycology
Cluster Adjustment and Outcome Selection May Overstate Completion Benefits of Shorter Pediatric Tuberculosis Regimens
More on the Role of Shorter Pediatric Tuberculosis Regimens
Immunological Evaluation in Disseminated cutaneous and extracutaneous Tuberculosis: Recognising the Diagnostic Gaps
Interpreting the Mortality Difference Between Cefepime and Piperacillin-Tazobactam in Pseudomonas aeruginosa Pneumonia
Observational studies have limitations that warrant careful consideration; so does a meta-analysis of 3 decades worth of randomized controlled trials
Oral Fosfomycin for Pyelonephritis: Re-examining the Pooled Evidence
Defining the Immunologic Workup in a Child With Multifocal Cutaneous Tuberculosis
Immune persistence up to one year after a single dose of pentavalent meningococcal ACYWX conjugate vaccine (NmCV-5) administered to children, adolescents and adults (2-29 years of age) in Mali and The Gambia
Integrating Cost Considerations into HIV Care and Prevention to Achieve Population-Level Outcomes
House of Cards: Changing HIV Medication Utilization and Pricing Patterns Will Require a Funding Balancing Act
Transplant Infectious Disease Physician Workforce: A National Survey of Practice Structure, Compensation, and Job Satisfaction
Practice Structures and Compensation for Transplant Infectious Diseases: A First Step to Charting the Future of the Field
CAB-LA PrEP Prescriptions and Abandonment in the United States, January 2022–June 2025
National Trends in Congenital Syphilis Among US Newborns, 2012–2022
People With Influenza Requiring ICU Admission During the 2025–2026 Season, Marked by the Emergence of Influenza A(H3N2) Subclade K: A French Prospective Nationwide Cohort Study
Are Higher-Order Carbapenems Effective Therapy for Patients with Ertapenem-Resistant Enterobacterales Invasive Infections?
Myths and Misconceptions About Modern Antiretroviral Therapy for HIV Treatment
Searching for the Optimal Treatment of Infections due to Non-Carbapenemase-Producing Carbapenem-resistant Enterobacterales
Special Populations Require Special Research Approaches
Relationships between Schistosoma mansoni infection intensity, environmental enteric dysfunction (EED), and anemia type among preschool-aged children in Uganda
Volumes
2026 · 9802025 · 6652024 · 6622023 · 1,0212022 · 1,0632021 · 1,9422020 · 1,3602019 · 9712018 · 9322017 · 9452016 · 1,0342015 · 1,1812014 · 1,0482013 · 1,0082012 · 1,0772011 · 9012010 · 8472009 · 9332008 · 1,0132007 · 9622006 · 1,0002005 · 1,1572004 · 1,0232003 · 9142002 · 8262001 · 9222000 · 6871999 · 7881998 · 8831997 · 8621996 · 7831995 · 9271994 · 7121993 · 6981992 · 6321991 · 4701990 · 3291989 · 4221988 · 3701987 · 239
EUVIMED